An article in the November issue of "Transfusion" describes a new tool -- the Bleeding Severity Measurement Scale -- for assessing bleeding severity in patients with chemotherapy-induced thrombocytopenia. The authors state that "[a]lthough various bleeding measures exist, there is no standardized and validated method of assessment of bleeding severity in patients with CIT." The scale includes three grades: Grade 0, no bleeding; Grade 1, not clinically significant bleeding; and Grade 2, clinically significant bleeding. The researchers concluded that use of the scale in clinical trials should provide valid and reliable assessments of bleeding. Continuing medical education credits are being offered for reading and successfully completing a test on the article. Read the abstract or visit the CME website.